The move is part of bp's broader strategy to address investor concerns, reduce costs and boost returns on investments.

Endo Inc. said Tuesday it has entered into an agreement to divest its international pharmaceuticals business to Knight Therapeutics in a deal valued at up to $99 million. The proposed sale ...

Thalwil, Switzerland – 17 March 2025 – u-blox (SIX: UBXN), a global provider of leading positioning and wireless communication technologies and services, has signed an agreement to divest its Cellular ...

"The intent to divest TAPI will allow Teva to maximize current ... Teva API is a stand-alone business unit of Teva Pharmaceutical (TEVA) specializing in development and manufacturing of small ...

Metro Pacific Investments Corp. (MPIC) plans to divest up to 20-percent stake in its tollway unit to reduce debt, a top ...